Logo image of HEPS

D-MARKET ELECTRONIC SERV-ADR (HEPS) Stock Fundamental Analysis

NASDAQ:HEPS - Nasdaq - US23292B1044 - ADR - Currency: USD

2.65  -0.01 (-0.38%)

Premarket: 2.66 +0.01 (+0.38%)

Fundamental Rating

3

Taking everything into account, HEPS scores 3 out of 10 in our fundamental rating. HEPS was compared to 31 industry peers in the Broadline Retail industry. While HEPS seems to be doing ok healthwise, there are quite some concerns on its profitability. HEPS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HEPS has reported negative net income.
HEPS had a positive operating cash flow in the past year.
HEPS had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: HEPS reported negative operating cash flow in multiple years.
HEPS Yearly Net Income VS EBIT VS OCF VS FCFHEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2B -2B 4B

1.2 Ratios

The Return On Assets of HEPS (-6.54%) is worse than 64.52% of its industry peers.
Looking at the Return On Equity, with a value of -43.66%, HEPS is doing worse than 70.97% of the companies in the same industry.
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROIC N/A
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEPS Yearly ROA, ROE, ROICHEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

HEPS has a worse Gross Margin (35.27%) than 64.52% of its industry peers.
In the last couple of years the Gross Margin of HEPS has grown nicely.
The Profit Margin and Operating Margin are not available for HEPS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
HEPS Yearly Profit, Operating, Gross MarginsHEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20 30

More info and screens

5

2. Health

2.1 Basic Checks

HEPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
HEPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HEPS Yearly Shares OutstandingHEPS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 100M 200M 300M
HEPS Yearly Total Debt VS Total AssetsHEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 5B 10B 15B 20B

2.2 Solvency

HEPS has an Altman-Z score of 2.59. This is not the best score and indicates that HEPS is in the grey zone with still only limited risk for bankruptcy at the moment.
HEPS has a better Altman-Z score (2.59) than 61.29% of its industry peers.
HEPS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
HEPS has a better Debt to FCF ratio (0.35) than 90.32% of its industry peers.
HEPS has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.44, HEPS is in line with its industry, outperforming 41.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Altman-Z 2.59
ROIC/WACCN/A
WACC30.95%
HEPS Yearly LT Debt VS Equity VS FCFHEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 1B 2B 3B 4B

2.3 Liquidity

HEPS has a Current Ratio of 1.02. This is a normal value and indicates that HEPS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of HEPS (1.02) is worse than 87.10% of its industry peers.
HEPS has a Quick Ratio of 1.02. This is a bad value and indicates that HEPS is not financially healthy enough and could expect problems in meeting its short term obligations.
HEPS has a Quick ratio of 0.66. This is in the lower half of the industry: HEPS underperforms 77.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.66
HEPS Yearly Current Assets VS Current LiabilitesHEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5B 10B 15B

More info and screens

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.92%

3.2 Future

The Earnings Per Share is expected to grow by 72.45% on average over the next years. This is a very strong growth
HEPS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 31.39% yearly.
EPS Next Y161.33%
EPS Next 2Y72.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year37.58%
Revenue Next 2Y31.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

HEPS Yearly Revenue VS EstimatesHEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
HEPS Yearly EPS VS EstimatesHEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4 -6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HEPS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 33.52 indicates a quite expensive valuation of HEPS.
The rest of the industry has a similar Price/Forward Earnings ratio as HEPS.
When comparing the Price/Forward Earnings ratio of HEPS to the average of the S&P500 Index (22.10), we can say HEPS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 33.52
HEPS Price Earnings VS Forward Price EarningsHEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HEPS is on the same level as its industry peers.
HEPS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HEPS is cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.87
EV/EBITDA 18.86
HEPS Per share dataHEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HEPS's earnings are expected to grow with 72.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y72.45%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HEPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

D-MARKET ELECTRONIC SERV-ADR

NASDAQ:HEPS (5/28/2025, 8:00:02 PM)

Premarket: 2.66 +0.01 (+0.38%)

2.65

-0.01 (-0.38%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)06-13 2025-06-13
Inst Owners14.19%
Inst Owner Change25.11%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap863.90M
Analysts82.22
Price Target4.23 (59.62%)
Short Float %2.35%
Short Ratio2.53
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.52
P/S 0.54
P/FCF 6.87
P/OCF 5.09
P/B 9.2
P/tB 36.86
EV/EBITDA 18.86
EPS(TTM)-0.13
EYN/A
EPS(NY)0.08
Fwd EY2.98%
FCF(TTM)0.39
FCFY14.56%
OCF(TTM)0.52
OCFY19.66%
SpS4.93
BVpS0.29
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.54%
ROE -43.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.27%
FCFM 7.82%
ROA(3y)-11.34%
ROA(5y)-14.4%
ROE(3y)-45.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.14%
GM growth 5Y6.31%
F-Score4
Asset Turnover2.57
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 0.35
Debt/EBITDA 1
Cap/Depr 94.74%
Cap/Sales 2.74%
Interest Coverage N/A
Cash Conversion 413.77%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.66
Altman-Z 2.59
F-Score4
WACC30.95%
ROIC/WACCN/A
Cap/Depr(3y)121.47%
Cap/Depr(5y)110.53%
Cap/Sales(3y)3.7%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y161.33%
EPS Next 2Y72.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%62.92%
Revenue Next Year37.58%
Revenue Next 2Y31.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year252.1%
EBIT Next 3Y95.44%
EBIT Next 5YN/A
FCF growth 1Y411.4%
FCF growth 3Y124.57%
FCF growth 5Y100.63%
OCF growth 1Y855.4%
OCF growth 3Y124.87%
OCF growth 5Y97.22%